Article Details

AstraZeneca and Ionis sign deal to develop and commercialise eplontersen | MarketScreener

Retrieved on: 2021-12-07 21:26:23

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca and Ionis sign deal to develop and commercialise eplontersen | MarketScreener. View article details on hiswai:

Excerpt

AstraZeneca has entered into a new global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up